Early identification of prodromes in neurodegenerative diseases is of great importance for understanding the course of and potential for interventions in progressive cognitive change. Prodromal Alzheimer's disease may manifest in multiple cognitive domains, including memory or executive deficits, making it difficult to distinguish from other prodromal pathophysiologies such as frontotemporal dementia. This project addresses this difficulty by combining structural and functional markers of network integrity with novel measures of white matter disruption using the recently developed NIH Human Connectome Project scanner. This state-of-the-art instrument was developed for high fidelity imaging of the integrity of white matter fiber tracts, but also allows conventional imaging. These technical advantages are leveraged by the project aims. The project focus is on subjects with subjective cognitive concerns or mild cognitive impairment exhibiting a phenotype of predominant executive dysfunction or of predominant memory deficits.
Aim 1 will test the hypothesis that these two cognitive phenotypes will be associated with structural and functional connectivity measures of the integrity in different networks.
Aim 2 will test the hypothesis that novel measures of white matter integrity using diffusion imaging on the Connectome Project scanner will improve sensitivity to early impairments in the these two cognitive phenotypes when paired with the structural and functional connectivity measures developed in Aim 1. Because of the novelty of the Connectome methods, we will assess the sensitivity of fiber tract identification and integrity compared to conventional methods across a 3-year follow-up interval in a subset of subjects. The project addresses a growing need for early identification and differential diagnosis of individuals who will go on to develop different neurodegenerative diseases so that they can be targeted for participation in clinical trials or lifestyle interventions. Successful completion of the aims will contribute novel neuroimaging markers of prodromal neurodegenerative diseases and will further scientific knowledge of the relationship between functional network integrity and the integrity of fiber tracts connecting key nodes within a network.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005134-31
Application #
8676356
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (J1))
Project Start
2014-04-01
Project End
2019-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
31
Fiscal Year
2014
Total Cost
$217,500
Indirect Cost
$92,500
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Dujardin, Simon; Bégard, Séverine; Caillierez, Raphaëlle et al. (2018) Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun 6:132
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
DeVos, Sarah L; Corjuc, Bianca T; Commins, Caitlin et al. (2018) Tau reduction in the presence of amyloid-? prevents tau pathology and neuronal death in vivo. Brain 141:2194-2212
Lee, Christopher M; Jacobs, Heidi I L; Marquié, Marta et al. (2018) 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. J Alzheimers Dis 62:1691-1702
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Emerson, Sarah C; Waikar, Sushrut S; Fuentes, Claudio et al. (2018) Biomarker validation with an imperfect reference: Issues and bounds. Stat Methods Med Res 27:2933-2945
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739

Showing the most recent 10 out of 966 publications